Hillary M Peltier

This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Janssen Pharmaceutica Nv, Abbvie Inc.. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hillary M Peltier. Retrieved from https://idiyas.com/inventor/hillary-m-peltier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 9.9

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

San Diego, CA (US) (2014)
Evanston, IL (US) (2015 - 2018)
Evanston, CA (US) (2020 - 2023)

Company Filing History:

5 out of 2,101

Janssen Pharmaceutica Nv

Years Active: 2014-2023

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11618744 - Benzoimidazoles as prolyl hydroxylase inhibitors (2023-04-04),

2. 10851083 - Benzoimidazoles as prolyl hydroxylase inhibitors (2020-12-01),

3. 9969693 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use (2018-05-15),

4. 9452986 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use (2016-09-27),

5. 9073923 - Benzoimidazoles as prolyl hydroxylase inhibitors (2015-07-07),

6. 8865713 - Benzoimidazoles as prolyl hydroxylase inhibitors (2014-10-21),

7. 8759345 - Benzoimidazoles as prolyl hydroxylase inhibitors (2014-06-24),

Title: Exploring the Innovative Mind of Hillary M Peltier

Introduction:

Hillary M Peltier, a brilliant inventor based in San Diego, CA, has made significant contributions to the world of pharmaceuticals through his groundbreaking inventions. With a total of 7 patents under his belt, Peltier is a trailblazer in the field of prolyl hydroxylase inhibitors.

Latest Patents:

One of Peltier's latest patents revolves around benzoimidazole compounds that act as prolyl hydroxylase inhibitors. These compounds have shown promise in pharmaceutical compositions aimed at treating various disease states, disorders, and conditions related to prolyl hydroxylase activity.

Career Highlights:

Throughout his career, Hillary M Peltier has showcased a deep understanding of medicinal chemistry and drug development. His work at esteemed companies like Janssen Pharmaceutica Nv and AbbVie Inc. has been instrumental in pushing the boundaries of pharmaceutical innovation.

Collaborations:

Peltier has had the privilege of collaborating with top-notch professionals in the industry, including Frances Meredith Hocutt and Barry Eastman Leonard, Jr. Their combined expertise has led to the successful creation of novel pharmaceutical compounds that have the potential to revolutionize the field.

Conclusion:

In conclusion, Hillary M Peltier stands out as a visionary inventor who continues to make waves in the pharmaceutical world. His dedication to advancing drug development and improving patient outcomes serves as a testament to his innovative spirit and unwavering commitment to scientific excellence.

Profile summary based on public USPTO records.